Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 3
2019 1
2020 4
2021 2
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Impact of Manufacturing Procedures on CAR T Cell Functionality.
Watanabe N, Mo F, McKenna MK. Watanabe N, et al. Among authors: mo f. Front Immunol. 2022 Apr 13;13:876339. doi: 10.3389/fimmu.2022.876339. eCollection 2022. Front Immunol. 2022. PMID: 35493513 Free PMC article. Review.
Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer.
Kemp SB, Cheng N, Markosyan N, Sor R, Kim IK, Hallin J, Shoush J, Quinones L, Brown NV, Bassett JB, Joshi N, Yuan S, Smith M, Vostrejs WP, Perez-Vale KZ, Kahn B, Mo F, Donahue TR, Radu CG, Clendenin C, Christensen JG, Vonderheide RH, Stanger BZ. Kemp SB, et al. Among authors: mo f. Cancer Discov. 2023 Feb 6;13(2):298-311. doi: 10.1158/2159-8290.CD-22-1066. Cancer Discov. 2023. PMID: 36472553 Free PMC article.
Engineered off-the-shelf therapeutic T cells resist host immune rejection.
Mo F, Watanabe N, McKenna MK, Hicks MJ, Srinivasan M, Gomes-Silva D, Atilla E, Smith T, Ataca Atilla P, Ma R, Quach D, Heslop HE, Brenner MK, Mamonkin M. Mo F, et al. Nat Biotechnol. 2021 Jan;39(1):56-63. doi: 10.1038/s41587-020-0601-5. Epub 2020 Jul 13. Nat Biotechnol. 2021. PMID: 32661440 Free PMC article.
Taking T-Cell Oncotherapy Off-the-Shelf.
Mo F, Mamonkin M, Brenner MK, Heslop HE. Mo F, et al. Trends Immunol. 2021 Mar;42(3):261-272. doi: 10.1016/j.it.2021.01.004. Epub 2021 Feb 1. Trends Immunol. 2021. PMID: 33536140 Free PMC article. Review.
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies.
Watanabe N, Mo F, Zheng R, Ma R, Bray VC, van Leeuwen DG, Sritabal-Ramirez J, Hu H, Wang S, Mehta B, Srinivasan M, Scherer LD, Zhang H, Thakkar SG, Hill LC, Heslop HE, Cheng C, Brenner MK, Mamonkin M. Watanabe N, et al. Among authors: mo f. Mol Ther. 2023 Jan 4;31(1):24-34. doi: 10.1016/j.ymthe.2022.09.003. Epub 2022 Sep 9. Mol Ther. 2023. PMID: 36086817 Free PMC article.
CRISPR-Edited Immune Effectors: The End of the Beginning.
Mo F, Heslop HE, Mamonkin M. Mo F, et al. Mol Ther. 2020 Apr 8;28(4):995-996. doi: 10.1016/j.ymthe.2020.03.009. Epub 2020 Mar 22. Mol Ther. 2020. PMID: 32203679 Free PMC article. No abstract available.
CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia.
Gomes-Silva D, Atilla E, Atilla PA, Mo F, Tashiro H, Srinivasan M, Lulla P, Rouce RH, Cabral JMS, Ramos CA, Brenner MK, Mamonkin M. Gomes-Silva D, et al. Among authors: mo f. Mol Ther. 2019 Jan 2;27(1):272-280. doi: 10.1016/j.ymthe.2018.10.001. Epub 2018 Oct 4. Mol Ther. 2019. PMID: 30391141 Free PMC article.
14 results